about
Single cell analysis of drug distribution by intravital imagingCombination Radioimmunotherapy Approaches and Quantification of Immuno-PETCurrent advances in mathematical modeling of anti-cancer drug penetration into tumor tissuesQuantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imagingTailoring Adjuvant Radiation Therapy by Intraoperative Imaging to Detect Residual Cancer.A mechanistic tumor penetration model to guide antibody drug conjugate designQuantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.Endothelial Thermotolerance Impairs Nanoparticle Transport in Tumors.Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design.Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitorsHeterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.Spatial frequency analysis of anisotropic drug transport in tumor samples.Importance of Drug Pharmacokinetics at the Site of ActionDrug delivery in a tumour cord model: a computational simulationVaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth.A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumorsBacterial delivery of Staphylococcus aureus α-hemolysin causes regression and necrosis in murine tumors.Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumorsSingle-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo.Quorum-sensing Salmonella selectively trigger protein expression within tumorsQuantifying and Reducing Uncertainties in Cancer Therapy.Spatial Modeling of Drug Delivery Routes for Treatment of Disseminated Ovarian CancerAdvances in measuring single-cell pharmacology in vivo.Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target AntigenSerial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101Therapy operating characteristic curves: tools for precision chemotherapy.Efficient (18)F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta CellsPrediction of drug disposition on the basis of its chemical structure.Intratumor heterogeneity and its impact on drug distribution and sensitivity.Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.Mathematical and computational models of drug transport in tumours.Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for Efficacy.Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging Agents.Cancer nanomedicine: progress, challenges and opportunities.Towards an integrated systems-based modelling framework for drug transport and its effect on tumour cells.Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.A mechanistic compartmental model for total antibody uptake in tumors.A multiscale modeling study of particle size effects on the tissue penetration efficacy of drug-delivery nanoparticles.Microscopic investigation of topically applied nanoparticles for molecular imaging of fresh tissue surfaces.
P2860
Q21133568-1090C0F0-2E22-4B4D-B5A1-D631ED0C85D2Q26747546-E89C798B-55D2-4526-BFBB-4D19F598B438Q26827129-02EBC431-7E51-48C5-B093-AA072384E99DQ27023605-122CAF82-10C6-427B-A481-8AC7402E41D9Q28084315-423E2C40-1662-46B4-AF85-EB7426C2E5D8Q28544636-17BF282A-EA14-4828-889D-F8D74BA57D39Q30364628-F41516BC-DD6E-4DF2-838E-99C55657BFAAQ30376502-DE20FF89-D6AD-4C39-BB08-30FCA96C029EQ30383551-CF1E38B5-C9C2-43E7-874A-ADA4188B3D0CQ30575798-8B2E1BFF-5A47-4F4C-BA95-442577C3D6FEQ30838654-F70988EF-96D5-45A0-9B3F-2BAC8627CA89Q33604052-41944A8A-2CCC-46C9-ADB4-4DD04E4E3F03Q33648045-4868D9E7-6325-4584-A32A-7AB8B29983FAQ33748082-9B9947DD-EBBF-4889-A770-255FDD93BA75Q33763847-36E48D66-31AB-4905-A74B-5F8AB48435A4Q33855309-D6206681-C874-4C4A-86F8-1D547C6A24CDQ33870710-AF1466FD-3FE9-45A6-9544-9FE702EF1279Q34241923-44F3E341-5E96-4974-BA8B-246BF5526E28Q34592125-54509156-DA31-492C-9132-9C8EF86FD8ADQ35212564-B38F8C28-968D-44E6-AD2A-86BFD03A1EAEQ35836336-DFA48A3C-3E5C-4901-9C94-521B24237D76Q35882323-26414D8D-E6F8-45CC-8100-34E59FF22B4AQ36054366-134E999E-F0CD-412E-8C45-2B884AEC1DBEQ36056627-10556632-9212-4D27-BFD2-3BBB1EB97B03Q36815253-5A69CC2F-8164-45D8-AA48-F22E9446A073Q36855062-25E08BCF-F4F0-49B6-8511-8E840E3D872DQ37134464-FCA12C41-EC1A-48FA-AAC3-C4A4E7DCE457Q38086778-89F9A418-9F00-4E5F-A3EC-3083A0746D53Q38211694-F5AFD5E8-F3AE-4014-B7A0-112617B991B1Q38350045-63527E9A-8286-4641-BC7E-1A5DE481C4C6Q38392523-EF8397C7-A203-4E39-9CD0-7B3868D32F3BQ38594401-04AECA10-A886-43C1-8067-E28A039ECC9DQ38765188-09D64788-AE1A-4BAB-89B3-302F4BFFCAE7Q38887857-1294A9B0-6B36-40B2-8AB7-A35729620780Q39005226-70352DA7-9989-4522-B697-772368105FB6Q41814813-2955F9FA-D2E0-45A9-8E4E-DBC3549461A3Q42145728-EF2EE2B2-9807-463C-92B2-56FD27E6519DQ43066289-B2CF36B9-472B-4785-BC63-8B661346D407Q47163806-CF9C6FC2-4AFE-4F31-8931-3C903D40E478Q47262062-6A952CAE-3C75-436C-89D9-1FC1321D3B9D
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A systems approach for tumor pharmacokinetics
@ast
A systems approach for tumor pharmacokinetics
@en
A systems approach for tumor pharmacokinetics
@nl
type
label
A systems approach for tumor pharmacokinetics
@ast
A systems approach for tumor pharmacokinetics
@en
A systems approach for tumor pharmacokinetics
@nl
prefLabel
A systems approach for tumor pharmacokinetics
@ast
A systems approach for tumor pharmacokinetics
@en
A systems approach for tumor pharmacokinetics
@nl
P2860
P3181
P1433
P1476
A systems approach for tumor pharmacokinetics
@en
P2093
Greg Michael Thurber
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0024696
P407
P577
2011-09-14T00:00:00Z